보행동결 치료 시장 규모는 지난 몇년간 대폭적인 성장률로 급성장하고 있으며, 시장추계·예측기간(2021-2028년)에는 크게 성장할 것으로 예측되고 있습니다.
파킨슨 병 유병률 증가가 보행동결 치료 시장의 성장을 견인하며, 세계 노년 인구 증가가 보행동결 치료 시장의 가장 큰 촉진요인입니다. 보행동결 치료 세계 시장 보고서는 시장의 전반적인 평가를 제공합니다 주요 부문, 동향, 시장 성장 촉진요인, 억제요인, 경쟁 구도, 시장에서 중요한 역할을 하는 요인 등을 종합적으로 분석했습니다.
세계의 보행동결 치료 시장 정의
보행동결(FOG)은 파킨슨 병의 도파민 저항성 운동 증상 중 하나로 여겨지는 경우가 많습니다. 발병률은 3%에서 5%로 상승합니다. 걷는 데 어려움과 균형 장애를 일으킬 수 있습니다.
구부정한 자세, 보행동결(FOG) 가속, 쪼그리고 넘어지는 것은 모두 PD에서 자주 볼 수있는 보행 장애입니다. 스트레스, 주의 산만에 직면할 때 단계의 시작과 소용돌이 때 가장 발생합니다. 엔타카폰 치료는 최근 연구에서 Off-관련 FOG를 개선하는 것으로 나타났습니다. FOG는 다른 많은 증상과 마찬가지로 가장 진행된 단계에서만 치료에 내성을 나타냅니다.
현재까지 레보도파는 파킨슨 병 치료의 골드 표준입니다.레보도파는 운동 증상을 상당히 개선할 수 있습니다. 레포도파는 아키네지아와 FOG의 에피소드 수를 유의하게 감소시킵니다. FOG에서 넘어짐을 줄이는 것으로 나타났습니다.
보행동결 치료 세계 시장 개요
파킨슨 병 유병률 증가는 보행동결 치료 시장의 성장을 가속하고 있습니다. 환자와 가족 모두에게 큰 부담이 되고 있습니다. 운동(디스패치 메커니즘 장애)과 비 운동(인지 기능 저하, 불안)의 상호 작용을 포함하는 종합적인 병태 생리, 여러 신경 연결 장애를 포함한 복잡한(그리고 아마도 이질적인) 기본 신경 기초와 같은 다양한 요인으로 인해 어려움이 있습니다. 이 질병은 파킨슨 병과 관련되어 시장이 건강하게 성장할 것으로 예상됩니다.
세계 노년 인구 증가는 시장의 가장 큰 촉진요인입니다. 이러한 질병은 여성보다 남성이 악화하기 쉽다는 것이 밝혀졌습니다. 마나 만성 질환이나 치명적인 질병에 걸릴 가능성이 높을 뿐만 아니라, 척추나 관절의 통증 등, 평생에 걸쳐 통증을 일으키는 장애에 걸릴 가능성도 높기 때문입니다. 부작용을 일으키는 환자도 있기 때문에 보행동결 치료 시장의 성장이 억제될 가능성이 있습니다.
Freezing Of Gait Treatment Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2021 to 2028.
Increasing prevalence of Parkinson's disease driving the growth of the Freezing Of Gait Treatment Market. The growing geriatric population worldwide is the biggest driver of the Freezing Of Gait Treatment Market. The Global Freezing Of Gait Treatment Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Freezing Of Gait Treatment Market Definition
Freezing of gait (FOG) is frequently regarded as one of the dopamine-resistant motor symptoms of Parkinsonism. Parkinson's disease is the second most prevalent neurodegenerative disorder, impacting about 1% of adults over 60 years of age. In persons above the age of 85, the incidence rises from 3% to 5%. Bradykinesia, resting tremor, rigidity, and lack of postural reflexes are the most common symptoms. As the disease progresses, most people with PD lose their postural reflexes, leading to walking difficulties and balance problems.
Stooped posture, freezing of gait (FOG) festination, shuffling steps, and falling are all common PD gait disorders. FOG, defined as an onset of inability to start effective steps without a known cause, is most particularly experienced during step initiation and turning, especially facing obstacles, doorways, stress, and distraction. Treatment with levodopa (L-dopa) or entacapone has been shown to improve Off-related FOG in recent studies. L-dopa has been shown to reduce the duration and frequency of FOG episodes. On-related FOGs are uncommon and difficult to diagnose. FOGs, like many other symptoms, are only resistant to treatment at the most advanced stages of the disease.
To date, Levodopa is the gold standard for Parkinson's disease treatment. Levodopa can considerably improve the symptoms of movement. High-dose levodopa can delay and reduce the occurrence of FOG when compared to placebo or low-dose levodopa. Levodopa can significantly decrease the number of episodes of akinesia and FOG. Levodopa can also reduce the frequency and duration of 'off'-related FOG. Deep brain stimulation (DBS) has been shown to improve FOG and reduce falls in FOG.
Global Freezing Of Gait Treatment Market Overview
Increasing prevalence of Parkinson's disease driving the growth of the Freezing Of Gait Treatment Market. Freezing of gait is a common symptom of Parkinson's syndrome and several other forms of parkinsonism. Freezing is a major burden for both patients and families since it often leads to falls, injuries from falls, and a loss of independence. Treatment of gait freezing is difficult due to a variety of factors, including its paroxysmal and changeable nature; comprehensive pathophysiology encompassing an interplay among motor (disturbed stepping mechanisms) and non-motor (cognitive decline, anxiety); and a complex (and likely heterogeneous) fundamental neural substrate, which includes multiple failing neural connections. As the disease is correlated with Parkinson's disease, the market is expected to grow healthy.
The growing geriatric population worldwide is the biggest driver of the market. According to a study, around 60,000 Americans are diagnosed with Parkinson's disease every year, therefore the market in North America has a lot of potential. Furthermore, it has been discovered that men are more vulnerable to developing such diseases than women. The rise in the geriatric population is also benefitting the Freezing Of Gait Treatment Market, since older people are more likely to become ill and suffer a variety of chronic or fatal diseases, as well as disorders that cause them pain throughout their life, such as spinal or joint pain. However, some patients develop side effects after taking medications related to the freezing of gait which might restrain the Freezing Of Gait Treatment Market growth.
The Global Freezing Of Gait Treatment Market is segmented on the basis of Product Type, Application, And Geography.
Based on Product Type, The market is segmented into Carbidopa/Levodopa, Deep Brain Stimulation, and Wearable and Walking Aid Devices. Carbidopa/Levodopa segment is expected to grow at a significant rate during forecasted years. To date, Levodopa is the gold standard for Parkinson's disease treatment. Levodopa can significantly decrease the number of episodes of akinesia and FOG.
Based on Application, The market is segmented into Hospitals, Clinics, and Others. The Hospitals segment is expected to grow at a significant rate during the forecasted years. This is owing to, symptomatic and neuroprotective therapies being preferred in Hospitals, according to FDA and other research studies.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.